ArticleCell death & disease2026

Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.

Sivasundaram Karnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.